Literature DB >> 11412072

Rituximab for bone lymphoma.

D G Savage, R Staron.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11412072     DOI： 10.7326/0003-4819-134-12-200106190-00032

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  2 in total

1.  Dramatical improvement of chemoresistant bone lymphoma with rituximab.

Authors:  Lahsen Achemlal; Mohamed Mikdame; Abderrazak Nouijai; Ahmed Bezza; Abdellah El Maghraoui
Journal:  Clin Rheumatol       Date:  2005-10-25       Impact factor: 2.980

Review 2.  Primary bone lymphoma.

Authors:  C Míguez Sánchez; M L Hebrero; C Mesa; I Villanego; J A Sánchez Calzado; L Errazquin
Journal:  Clin Transl Oncol       Date:  2006-03       Impact factor: 3.405
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.